Summary: At its Investor Day on October 1, Harmony Biosciences presented a pipeline update, highlighting progress in its sleep disorder treatments. New data from the orexin-2 agonist BP1.15205 showed potential best-in-class potency, while long-term extension data for pitolisant … [Read more...]
FDA Review of Movano Health’s EvieMED Ring Advances
Summary: Movano Health had an in-person meeting with the US Food and Drug Administration (FDA) on Aug 15 to discuss the wellness features of its EvieMED Ring. The meeting resulted in the advancement of the review process for the device, which includes both medical and wellness … [Read more...]
Harmony Advances Pitolisant High-Dose Development Program
Summary: Harmony Biosciences reported strong second-quarter results and advancements in its pitolisant high-dose (HD) development program, aiming for a PDUFA date in 2028. The company highlighted revenue growth driven by Wakix and continued progress across its sleep/wake disorder … [Read more...]
Alkermes Reports Q2 Advances in Narcolepsy Therapy With ALKS 2680 Results
Summary: Alkermes reported its Q2 2024 financial performance and advances in the development of narcolepsy treatments, particularly with the investigational drug ALKS 2680. The company highlighted its financial position, double-digit growth, and progress in its neuroscience … [Read more...]
Sleep-Based Dementia Research Advances with Grant Funding
Summary: Corundum Neuroscience awarded a research grant to Tel Aviv University to develop a machine learning-based method for non-invasive detection of abnormal brain activity in deep brain regions during sleep. Led by professor Yuval Nir, the project aims to identify brain … [Read more...]
Advances in Sleep Apnea & Down Syndrome Management: Earn Continuing Education
Conditions for CSTE Qualification The Board of Registered Polysomnographic Technologists (BRPT) designates this instructional activity–Sleep Review’s 2023 Digital Edition series—for a optimum of 3.5 Continuing Snooze Technologies Training (CSTE) credits. People today ought to … [Read more...]